Cutaneous bacterial infections in the newborn

Current Opinion in Pediatrics

Volumn 17, Issue 4, 2005, Pages 481-485

  Larson, April A ^a   Dinulos, James G H ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Antimicrobial peptides; Cutaneous bacterial infections; Emollient; Methicillin resistant staphylococcus aureus; Neonate

Indexed keywords

ALPHA DEFENSIN; ANTIBIOTIC AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; CATHELICIDIN; DALBAVANCIN; DAPTOMYCIN; EMOLLIENT AGENT; LINEZOLID; ORITAVANCIN; PLACEBO; POLYPEPTIDE ANTIBIOTIC AGENT; SUNFLOWER OIL; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; VANCOMYCIN; XIPAMIDE;

BACTERIAL SKIN DISEASE; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; EPIDERMIS; HOSPITAL INFECTION; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; KLEBSIELLA; META ANALYSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEWBORN INFECTION; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS INFECTION;

ANTIMICROBIAL CATIONIC PEPTIDES; EPIDERMIS; HUMANS; IMMUNITY, NATURAL; INFANT, NEWBORN; SKIN DISEASES, BACTERIAL; VERNIX CASEOSA;

EID: 23344443106     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mop.0000171321.68806.bd     Document Type: Review

References (26)

1. Yang J, Yu Y, Sun S, et al. Ceramide and other sphingolipids in cellular responses. Cell Biochem Biophys 2004; 40:323-350. This is an excellent review of ceramide biology and the multiple cellular functions of these lipids. This is a comprehensive review for one interested in understanding the basic science of sphingolipids.
2. Kalia YN, Nonato LB, Lund CH, et al. Development of skin barrier function in premature infants. J Invest Dermatol 1998; 111:320-326.
3. Hoeger PH, Schreiner V, Klaassen IA, et al. Epidermal barrier lipids in human vernix caseosa: corresponding ceramide pattern in vernix and fetal skin. Br J Dermatol 2002; 146:194-201.
4. Rippke F, Schreiner V, Schwanitz HJ. The acidic milieu of the horny layer: new findings on the physiology and pathophysiology of skin pH. Am J Clin Dermatol 2002; 3:261-272.
5. da Cunha ML, Procianoy RS. Effect of bathing on skin flora of preterm newborns. J Perinatol 2005 This interesting study examined the role of neutral lipid soap in cutaneous bacterial colonization. The results support the idea that soap is not necessary each time an infant is bathed.
6. Visscher MO, Narendran V, Pickens WL, et al. Vernix caseosa in neonatal adaptation. J Perinatol 2005 The authors combined four studies in one article, making systematic review difficult. The results point to a vital role for vernix caseosa in neonatal adaptation. Further studies will need to be conducted to enable us to learn more about the underlying mechanisms responsible for these findings.
7. Izadpanah A, Gallo RL. Antimicrobial peptides. J Am Acad Dermatol 2005; 52:381-390; quiz 391-392. This is an excellent review on antimicrobial peptides written by experts in this field. The article is very well written and has supporting illustrations.
8. Dorschner RA, Lin KH, Murakami M, et al. Neonatal skin in mice and humans expresses increased levels of antimicrobial peptides: innate immunity during development of the adaptive response. Pediatr Res 2003; 53:566-572.
9. Marchini G, Lindow S, Brismar H, et al. The newborn infant is protected by an innate antimicrobial barrier: peptide antibiotics are present in the skin and vernix caseosa. Br J Dermatol 2002; 147:1127-1134.
10. Yoshio H, Tollin M, Gudmundsson GH, et al. Antimicrobial polypeptides of human vernix caseosa and amniotic fluid: implications for newborn innate defense. Pediatr Res 2003; 53:211-216.
11. Akinbi HT, Narendran V, Pass AK, et al. Host defense proteins in vernix caseosa and amniotic fluid. Am J Obstet Gynecol 2004; 191:2090-2096. These investigators used molecular techniques to characterize antimicrobial peptides in vernix caseosa. More studies such as this one should be done to assist us in understanding the role of vernix caseosa in antimicrobial defense.
12. Murakami M, Dorschner RA, Stern LJ, et al. Expression and secretion of cathelicidin antimicrobial peptides in murine mammary glands and human milk. Pediatr Res 2005; 57:10-15. The cathelicidin group of antimicrobial peptides is one of the major classes of cutaneous antimicrobial peptides. This article examines the content of cathelicidins in human milk, which may be protective against bacterial infection.
13. Pivarcsi A, Bodai L, Rethi B, et al. Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol 2003; 15:721-730.
14. Chao SC, Richard G, Lee JY. Netherton syndrome: report of two Taiwanese siblings with staphylococcal scalded skin syndrome and mutation of SPINK5. Br J Dermatol 2005; 152:159-165.
15. Mandel D, Littner Y, Mimouni FB, et al. Nosocomial cutaneous abscesses in septic infants. Arch Dis Child Fetal Neonatal Ed 2004; 89:F161-F162. The vast majority of skin infections are superficial. These authors show that deeper infections such as cutaneous abscesses are able to produce bacteremia. An infant with bacteremia without a known cause should be examined for cutaneous abscesses.
16. Sawardekar KP. Changing spectrum of neonatal omphalitis. Pediatr Infect Dis J 2004; 23:22-26. This article reports on the impact of home deliveries on the incidence of omphalitis in Oman. A decrease in home deliveries resulted in a decrease in the spectrum and severity of omphalitis.
17. Janssen PA, Selwood BL, Dobson SR, et al. To dye or not to dye: a randomized, clinical trial of a triple dye/alcohol regime versus dry cord care. Pediatrics 2003; 111:15-20.
18. Buescher ES. Community-acquired methicillin-resistant Staphylococcus aureus in pediatrics. Curr Opin Pediatr 2005; 17:67-70. This is an excellent review of MRSA as an emerging problem in children.
19. Arkwright PD, Daniel TO, Sanyal D, et al. Age-related prevalence and antibiotic resistance of pathogenic staphylococci and streptococci in children with infected atopic dermatitis at a single-specialty center. Arch Dermatol 2002; 138:939-941.
20. Conner JM, Soll RF, Edwards WH. Topical ointment for preventing infection in preterm infants. Cochrane Database Syst Rev 2004:CD001150. This meta-analysis examines the role of prophylactic application of emollients in infants. The reviewed studies were all conducted in industrialized countries, and the results may thus not be as applicable to developing countries.
21. Darmstadt GL, Saha SK, Ahmed AS, et al. Effect of topical treatment with skin barrier-enhancing emollients on nosocomial infections in preterm infants in Bangladesh: a randomised controlled trial. Lancet 2005; 365:1039-1045. This is one of the first studies to examine the role of topical emollients in the prevention of sepsis. A culturally sensitive emollient such as sunflower oil in Bangladesh may be a simple and effective measure to prevent sepsis.
22. Darmstadt GL, Badrawi N, Law PA, et al. Topically applied sunflower seed oil prevents invasive bacterial infections in preterm infants in Egypt: a randomized, controlled clinical trial. Pediatr Infect Dis J 2004; 23:719-725. This study was conducted in Egypt and showed that topical therapy with emollients may be a cost-effective measure to prevent sepsis in developing countries.
23. de Jager MW, Gooris GS, Dolbnya IP, et al. Novel lipid mixtures based on synthetic ceramides reproduce the unique stratum corneum lipid organization. J Lipid Res 2004; 45:923-932.
24. Segreti J. Efficacy of current agents used in the treatment of Gram-positive infections and the consequences of resistance. Clin Microbiol Infect 2005; 11(Suppl3): 29-35.
25. Mangili A, Bica I, Snydman DR, et al. Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2005; 40:1058-1060. This article describes a new antibiotic that may become applicable for bacterial cutaneous infections in newborns.
26. Anstead GM, Owens AD. Recent advances in the treatment of infections due to resistant Staphylococcus aureus. Curr Opin Infect Dis 2004; 17:549-555.